Evaluation of Clinical Response and Safety in HIV Positive Subjects Co-infected With Hepatitis C Treated With a Kaletra Containing HAART Regimen.
Phase of Trial: Phase IV
Latest Information Update: 02 Jan 2013
At a glance
- Drugs Lopinavir/ritonavir (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- Sponsors Abbott Laboratories
- 31 Aug 2018 Biomarkers information updated
- 02 Jan 2013 Status changed from discontinued to completed as reported by ClinicalTrials.gov.
- 02 Jan 2013 Last checked against clinicaltrials.gov record.